Results 211 to 220 of about 12,107,291 (301)

Gender bias in health financing methods: metrics and data. [PDF]

BMJ Glob Health
Chalkidou K, Sullivan R.
europepmc   +1 more source

Single‐cell DNA methylation profiling: Technologies, computation, and applications in precision oncology

Molecular Oncology, EarlyView.
Single‐cell DNA methylation (scDNAme) profiling maps epimutational clonal evolution, revealing mechanisms of malignancy and therapeutic resistance across diverse cancer types. By providing a high‐resolution landscape of intratumoral heterogeneity, these technologies empower precise patient stratification, guide the development of enhanced ...
Ik Soo Kim
wiley   +1 more source

Creating Equity? A Process Evaluation of Jamkesus Disabilitas , A Disability-Focused Health Financing Scheme in Yogyakarta, Indonesia

Azizatunnisa’ L, Kuper H, Probandari A, Banks LM.   +3 more
europepmc   +1 more source

Health systems performance in health outcomes, health financing and COVID-19 pandemic: Lessons from 31 countries. [PDF]

PLoS One
Kolivand P, Arabloo J, Saberian P, Dorooudi T, Rajaie S, Karimi F, Raei B, Behzadifar M, Parvari A, Ehsanzadeh SJ, Homayoun S, Salehbeigi S, Namdar P, Azari S.   +13 more
europepmc   +1 more source

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

Linking Health Financing to Oral Health Coverage and Disease Burden in SEARO Countries: A Cross-Sectional Analysis of Country Level Data. [PDF]

Int J Health Plann Manage
Acharya S, Mathur MR, Tadakamadla SK, Brand A.   +3 more
europepmc   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source

Implications of U.S. withdrawal from the World Health Organization on health financing in Africa. [PDF]

Health Policy Open
Sokunbi TO, Umar AB, Eyo UB.
europepmc   +1 more source

PANoptosis in the pathogenesis of myelodysplastic syndromes

Molecular Oncology, EarlyView.
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla, Jyoti Lamichhane, Cameron Lewis, Peter Breslin, Jiwang Zhang   +4 more
wiley   +1 more source

Public health financing in Brazil (2019-2022): an analysis of the national health fund and implications for health management. [PDF]

Front Public Health
Nunes Marinho L, Campbell SM, da S T Amaral IB, Reis E Silva R, Godman B, Meyer JC, Godói IPD.   +6 more
europepmc   +1 more source